Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADSK vs GSK✓SelectedUSD · GSKADSK vs GSK performance historyLatest closeAs of-0.87%11/18
Stock and ETF performance explorer

ADSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,526.1%
GSK return
+1,674.3%
Excess return
+3,851.8%
Maximum drawdown
-76.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.9%-1.3%+0.5%-0.4%
7D-2.7%-3.1%+0.4%-1.5%
30D+5.1%-0.9%+6.0%+5.5%
3M+2.5%-4.2%+6.7%+4.1%
6M+3.9%-1.6%+5.5%+4.1%
YTD-14.5%+2.6%-17.1%-16.5%
1Y-13.4%+6.2%-19.6%-16.5%
3Y+16.4%+55.0%-38.6%-6.0%
5Y-21.5%+42.8%-64.3%-35.7%
10Y+229.0%+102.1%+126.9%+133.3%
All+5,526.1%+1,674.3%+3,851.8%+1,504.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling